Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives $10.67 Average Target Price from Analysts

Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have been assigned an average rating of “Buy” from the six ratings firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, three have given a buy recommendation and two have assigned a […]

Leave a Reply

Your email address will not be published.

Previous post Brokerages Set Cincinnati Financial Corporation (NASDAQ:CINF) Target Price at $159.40
Next post Financial Survey: Array Digital Infrastructure (NYSE:AD) & iQSTEL (NASDAQ:IQST)